New posts

Sorriso Announces Data Publication in Lancet Gastroenterology & Hepatology and Presentation of New Findings at UEG 2025

Thread starter United Kingdom International Civil Aviation
Start date Friday at 8:33 AM

Friday at 8:33 AM

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Share

Copy link

First-in-class Oral Dual Acting Therapy SOR102 Demonstrates Promising Safety, Pharmacokinetics, and Efficacy in Ulcerative Colitis Patients SALT LAKE, UT, UNITED STATES, November 13, 2025 /⁨EINPresswire.com⁩/ -- Sorriso Pharmaceuticals, a …

Continue reading...

Click to expand...

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Already have an account? Log in here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

We value your privacy

We use essential cookies to make this site work, and optional cookies to enhance your experience. You can accept all cookies, reject optional cookies, or configure your preferences to choose which cookies to allow.

See further information and configure your preferences

Accept all cookies Reject optional cookies
Essential cookies

Required for core functionality, such as security, network management, and accessibility. You may not reject these cookies.

Optional cookies

Enable enhanced functionality and a personalized experience. If you reject these, certain functionalities may be unavailable.

Third-party cookies

Set by third-party service providers for purposes such as security, analytics, performance, and advertising. These cookies may also track your interaction with embedded media.

Detailed cookie usage

Privacy policy

Back

Top Bottom

Sorriso Announces Data Publication in Lancet Gastroenterology & Hepatology and Presentation of New Findings at UEG 2025

We value your privacy